Insights

Benchmark International Successfully Facilitated the Transaction Between Molzym GmbH & Co. KG and Bruker Daltonics GmbH & Co. KG

November 21, 2025

Benchmark International is pleased to announce the 100% acquisition of Molzym GmbH & Co. KG by Bruker Daltonics GmbH & Co. KG.

Molzym GmbH & Ko. KG, based in Bremen, Germany, is a leading company in biological research and the diagnosis of infectious agents, focusing on the development of new methods and products for the molecular detection of infectious diseases caused by bacteria and fungi. Founded by Prof. Lorenz, the company now sells its kits and reagents in over 30 countries.

Bruker Daltonics GmbH & Co. KG, headquartered in Bremen, Germany, the company employs over 9,700 people worldwide and provides high-performance scientific instruments and analytical and diagnostic solutions for researching biological and chemical processes at the molecular, cellular and microscopic levels.

Your Path to a Successful Sale Begins Here.

With the acquisition of Molzym, Bruker aims to strengthen its presence in biological research and the diagnosis of infectious diseases. The expertise, technology and good reputation are expected to help Bruker continue to grow.

“We are extremely pleased with this successful transaction. In Bruker, we have won a strong and experienced partner. We would also like to express our sincere thanks to everyone involved for their support during the process.” - Dr. Michael Lustig, Managing Director, Molzym GmbH & Co. KG

Benchmark International played a key role in managing the transaction process, from the initial offer through to completion. The team successfully guided the client through the entire process, including a thorough due diligence, ensuring a balanced structure that aligned with the strategic objectives of both parties.

“We are proud to have supported Molzym’s shareholders in securing this strategic acquisition by Bruker. This partnership combines two highly respected biotechnology innovators and positions both companies for continued advancement in molecular diagnostics and life sciences.” - Malte Bockholt, Transaction Lead, Benchmark International

Schedule a Call 

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Europe: Michael Lawrie at +44 (0) 161 359 4400 / [email protected]

Africa: Anthony McCardle at +27 21 300 2055 / [email protected] 

 

ABOUT BENCHMARK INTERNATIONAL:

Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled transactions across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network, as well as the #1 Sell-side Privately Owned M&A Advisor in the World by PitchBook’s and LSEG's Global League Tables.

The content provided by Benchmark International, including articles, blog posts, videos, and other media, is for general informational purposes only and does not constitute legal, financial, investment, or business advice. While we strive for accuracy, the information may be based on third-party sources, market trends, and evolving industry data that are not independently verified or guaranteed to be current or complete. Any opinions expressed are those of the authors and do not necessarily reflect the views of Benchmark International. Market trends, forecasts, and forward-looking statements are inherently uncertain and subject to change. Nothing in our content should be relied upon as a substitute for personalized advice from qualified professionals. Benchmark International disclaims all liability for any loss or damage resulting from reliance on this content. Always consult with appropriate experts before making business decisions.

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Verwandte Artikel
Wie Sie die richtigen Käufer Anziehen: Was ein Unternehmen wertvoller machtIn der dynamischen Welt der Fusionen und Übernahmen (M&A) ist der Verkauf Ihres Unternehmens ein komplexer Prozess, der strategische Planung, Bewertungsexpertise und ein Verständnis dafür erfordert, wonach potenzielle Käufer suchen. Käufer und Investoren werden von verschiedenen Motiven angetrieben, darunter Wachstumsbeschleunigung, Markterweiterung und Portfoliodiversifizierung. Wenn es gelingt, die richtigen Käufer zu gewinnen, kann dies den Verkaufspreis und den Gesamterfolg der Transaktion erheblich beeinflussen. Aber was genau kann Ihr Unternehmen wertvoller und attraktiver für potenzielle Käufer machen? Lassen Sie uns die Schlüsselfaktoren untersuchen, die die Attraktivität Ihres Unternehmens bei Fusionen und Übernahmen erhöhen können, und wie Sie Ihr Unternehmen so positionieren können, dass es möglichst attraktiv ist.Warum Verkaufsverfahren mit mehreren Bietern eine Chance für Käufer darstellenFür viele Erwerber haben die Worte "Wettbewerbsprozess" immer noch einen Unterton von Reibung. Sie suggerieren Ablenkung, überhöhte Erwartungen, unnötigen Druck und das Risiko, eher als Preisspannungsfaktor denn als ernsthafter Geschäftspartner benutzt zu werden. Doch diese Interpretation geht oft an der Realität vorbei. Für die meisten Unternehmenseigentümer, insbesondere für Gründer und langjährig tätige Unternehmer, ist ein Verkaufsprozess mit mehreren Parteien kein Akt der Aggression, sondern ein Akt der Verantwortung –  sich selbst, dem Unternehmen und dem Käufer gegenüber.
Sie finden nicht, wonach Sie suchen?
Sind Sie bereit, in unsere vorgestellten M&A-Inhalte einzutauchen und wertvolle Erkenntnisse für Ihr Unternehmen zu gewinnen?